Medical Review Policy
This policy defines when MedGuideGlobal may describe a clinical page as medically reviewed and when that page may be eligible for search indexing. A site-wide claim is not enough: the evidence must exist for the individual page.
Pages covered by the policy
The policy applies to medicine guides, condition guides, clinical articles, and country-specific medicine information. Calculators and experimental safety tools follow separate limitation notices and must not present their output as medical review or a safe treatment decision.
Mandatory page-level evidence
An indexable clinical page must identify a real reviewer by name, state relevant credentials or professional role, record a genuine review date, and link to specific authoritative references that support the page. A generic team label, publication date copied into a review field, regulator home page, or database search page does not satisfy the requirement.
Clinical review scope
Review covers the medicine or condition identity, intended uses, dosage or administration context, contraindications, interactions, adverse effects, pregnancy or population considerations, warnings, urgent-care guidance, uncertainty, and consistency with cited sources. The reviewer must be able to request revision, consolidation, noindex treatment, or withdrawal.
Release and re-review
Editorial approval and medical-review approval are separate controls. A page remains out of the sitemap until all mandatory checks pass. Material safety changes, corrections, conflicting evidence, or a change in local regulatory status can trigger re-review. An update timestamp is not automatically a medical review date.
Transparency and independence
Reviewer and reference details are displayed only when recorded for that page. Commercial relationships must not determine a clinical conclusion, redirect, comparison, or medicine recommendation. Readers can report a possible error through the contact page and review the corrections policy.